Regulus Therapeutics Inc. (RGLS) - Insider Holders & Insider Ownership

List of insiders holdings for Regulus Therapeutics Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	MOTT DAVID M 10% Owner	2019-12-26 17:01:47	0 15,922,758	15,922,758	Form 4
2	BARRIS PETER J 10% Owner	2019-12-26 16:57:51	0 15,922,758	15,922,758	Form 4
3	Viswanathan Ravi 10% Owner	2017-07-31 18:00:27	0 10,989,010	10,989,010	Form 3
4	Sakoda Jon 10% Owner	2017-07-31 17:59:06	0 10,989,010	10,989,010	Form 3
5	Puttagunta Chetan 10% Owner	2017-07-31 17:58:37	0 10,989,010	10,989,010	Form 3
6	Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC Former 10% Owner	2024-03-18 21:13:19	6,533,102 0	6,533,102	Form 13D
7	DENNER ALEXANDER J Sarissa Capital Management LP Sarissa Capital Offshore Master Fund LP Sarissa Capital Catapult Fund LLC Sarissa Capital Hawkeye Fund LP 10% Owner	2020-01-03 21:53:43	0 6,506,633	6,506,633	Form 4
8	MARAGANORE JOHN Director 10% Owner	2012-10-11 19:52:01	0 6,150,500	6,150,500	Form 4
9	ASTRAZENECA PLC ASTRAZENECA AB 10% Owner	2015-01-09 16:31:30	4,250,000 0	4,250,000	Form 13G
10	Sarissa Capital Offshore Master Fund LP 10% Owner	2020-05-08 20:03:50	4,039,390 0	4,039,390	Form 4
11	ISIS PHARMACEUTICALS INC 10% Owner	2015-07-31 17:19:59	2,843,172 0	2,843,172	Form 13D
12	ISIS PHARMACEUTICALS INC PARSHALL B LYNNE 10% Owner	2015-07-31 17:19:59	2,843,172 0	2,843,172	Form 13D
13	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner	2024-11-14 16:32:07	883,844 0	883,844	Form 13G
14	GRINT PAUL C President & CEO	2017-02-23 17:21:28	410,000 0	410,000	Form 4
15	XANTHOPOULOS KLEANTHIS G President and CEO	2015-04-21 19:06:32	214,637 80,216	294,853	Form 4
16	Sarissa Capital Master Fund II LP 10% Owner	2020-05-08 20:01:59	158,023 0	158,023	Form 3
17	WRIGHT TIMOTHY MICHAEL Chief R & D Officer	2019-02-06 16:52:33	102,893 0	102,893	Form 4
18	Drygin Denis Chief Scientific Officer	2022-03-01 17:58:56	100,000 0	100,000	Form 4
19	Deeg Mark Albert Chief Medical Officer	2018-05-21 16:39:25	100,000 0	100,000	Form 4
20	Simeonidis Simos Director	2022-06-10 16:16:01	90,000 0	90,000	Form 4
21	FOLETTA MARK G Director	2017-12-06 19:42:15	81,910 0	81,910	Form 4
22	Szekeres David Leslie Chief Business Officer & GC	2014-12-04 19:37:16	81,101 0	81,101	Form 4
23	Chevallard Daniel R. Chief Financial Officer	2019-07-02 17:41:20	77,870 0	77,870	Form 4
24	Menzel Garry E COO & Executive VP, Finance	2012-12-13 19:33:25	75,000 0	75,000	Form 4
25	WILLIAMS DOUGLAS E Director	2016-06-03 16:54:12	36,620 0	36,620	Form 4
26	Greene Barry E Director 10% Owner	2012-11-07 18:50:58	25,000 0	25,000	Form 4
27	CROOKE STANLEY T Director 10% Owner	2012-11-07 19:05:40	25,000 0	25,000	Form 4
28	CARTER BRUCE L A Director	2015-06-26 17:41:55	17,500 0	17,500	Form 4
29	CALSADA CRISPINA Chief Financial Officer	2025-06-27 16:58:38	0 0	0	Form 4
30	RASTETTER WILLIAM H Director	2025-06-27 17:12:53	0 0	0	Form 4
31	Witz Pascale Director	2025-06-27 17:12:43	0 0	0	Form 4
32	PAPADOPOULOS STELIOS Director	2025-06-27 17:11:47	0 0	0	Form 4
33	Rosen Hugh Director	2025-06-27 17:09:07	0 0	0	Form 4
34	Klassen Preston President & Head of R & D	2025-06-27 17:06:58	0 0	0	Form 4
35	Aker Christopher Ray Sr. VP & General Counsel	2025-06-27 17:06:29	0 0	0	Form 4
36	Hagan Joseph P Chief Executive Officer	2025-06-27 17:05:19	0 0	0	Form 4
37	BALTIMORE DAVID Director	2025-06-27 17:03:30	0 0	0	Form 4
38	Nunn Jason Raleigh Director	2025-06-27 17:02:30	0 0	0	Form 4
39	Huang Alice Shih-hou Director	2025-06-27 17:01:28	0 0	0	Form 4
40	Collier Kathryn J Director	2025-06-27 17:00:05	0 0	0	Form 4
41	Gibson Neil W Chief Scientific Officer	2015-01-30 17:45:43	0 0	0	Form 4
42	ALNYLAM PHARMACEUTICALS INC. 10% Owner	2017-08-09 17:01:58	0 0	0	Form 13G
43	Sanofi 10% Owner	2020-02-10 08:07:02	0 0	0	Form 13G
44	Walker Paul Edward Former 10% Owner	2021-03-16 20:46:58	0 0	0	Form 4
45	Sonsini Peter W. Former 10% Owner	2021-03-16 20:46:10	0 0	0	Form 4
46	SANDELL SCOTT D Former 10% Owner	2021-03-16 20:45:14	0 0	0	Form 4
47	MAKOWER JOSHUA Former 10% Owner	2021-03-16 20:44:11	0 0	0	Form 4
48	Makhzoumi Mohamad Former 10% Owner	2021-03-16 20:43:23	0 0	0	Form 4
49	Florence Anthony A. Jr. Former 10% Owner	2021-03-16 20:42:31	0 0	0	Form 4
50	Chang Carmen Former 10% Owner	2021-03-16 20:41:35	0 0	0	Form 4
51	Behbahani Ali Former 10% Owner	2021-03-16 20:40:36	0 0	0	Form 4
52	BASKETT FOREST Former 10% Owner	2021-03-16 20:39:41	0 0	0	Form 4